CTCBIO Inc (060590) — Cash Flow-to-Debt Ratio
CTCBIO Inc (060590) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of ₩5.64 Billion could theoretically repay 0% of its total liabilities (₩77.43 Billion) in one year. Explore investment intensity of CTCBIO Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CTCBIO Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for CTCBIO Inc across 12 annual periods. Also explore how large is CTCBIO Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for CTCBIO Inc (2013–2024)
Year-by-year debt coverage analysis for CTCBIO Inc. For market capitalisation and broader financial context, see market cap of CTCBIO Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩4.50 Billion | ₩84.07 Billion | ▼ -41.1% |
| 2023 | 0.09x | ₩8.22 Billion | ₩90.42 Billion | ▼ -54.2% |
| 2022 | 0.20x | ₩18.22 Billion | ₩91.94 Billion | ▲ +155.4% |
| 2021 | 0.08x | ₩6.46 Billion | ₩83.21 Billion | ▲ +1434.3% |
| 2020 | 0.01x | ₩510.09 Million | ₩100.86 Billion | ▼ -66.3% |
| 2019 | 0.01x | ₩1.68 Billion | ₩111.76 Billion | ▲ +163.5% |
| 2018 | -0.02x | ₩-2.47 Billion | ₩104.82 Billion | ▼ -1041.3% |
| 2017 | 0.00x | ₩295.30 Million | ₩117.82 Billion | ▼ -96.4% |
| 2016 | 0.07x | ₩6.86 Billion | ₩97.78 Billion | ▲ +361.4% |
| 2015 | 0.02x | ₩1.44 Billion | ₩94.47 Billion | ▲ +435.3% |
| 2014 | 0.00x | ₩-347.74 Million | ₩76.63 Billion | ▼ -109.6% |
| 2013 | 0.05x | ₩2.74 Billion | ₩58.25 Billion | — |